Pfizer is working to deal with typical business issues in the drug space, but its attempt at a solution has become very ...

Cogent Biosciences, Inc. stock soars after bezuclastinib's strong Phase 3 results in GIST. Click for my updated look at COGT ...

Markets have turned upbeat amid optimism that the 39-day US shutdown could soon come to an end, after a weekend of dealmaking in Washington. A new bill quickly advanced in a key S ...

S&P 500 gained 1.5 per cent, while the Nasdaq Composite gained 2.26 per cent, to 23,524.82. Read more at straitstimes.com.

Wall Street's main indexes gained on Monday, following signs of progress in Washington to end a record government shutdown ...

The prolonged shutdown has taken a toll on consumer confidence and the overall economy, with consumer sentiment dropping to ...

Wall Street rallied on Monday, led by big gains in Nvidia, Palantir and other heavyweight AI-related companies following ...

Nvidia (NVDA.O), the world's most valuable company, rose 5.8%. AI data analytics firm Palantir (PLTR.O) jumped 8.8% and Tesla (TSLA.O) climbed 3.7%.

The longest federal shutdown in history has created a data gap for the ... Metsera slumped 14.8% after Pfizer won a $10 billion bidding war to acquire the company. Eli Lilly rose 4.6% to a record high ...

WALL Street rallied on Monday, led by big gains in Nvidia, Palantir and other heavyweight AI-related companies following ...

WALL Street ended sharply higher on Monday, led by big gains in Nvidia, Palantir and other heavyweight AI-related companies ...

"Yes" is the answer from the top-performing investment newsletters among those monitored by my performance-auditing firm. These two losing stocks at the top of the list of their most-recommended ...